Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{718a9163119f4dbe9b2972f6ee1e0afe,
title = "Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache",
abstract = "Migraine is a common, severe disease, affecting the brain and blood vessels, causing much pain, time missed from work and family, and severe disability. It affects approximately 12{\%} of most Western populations studied and affects women three times more than men. Cluster headache is a much less common dysfunction of the hypothalamus, involving the sphenopalatine ganglion and other areas; it causes more frequent, shorter, and even more intense pain than migraine. The pain usually comes in cycles and is associated with ipsilateral autonomic features and associated with irritability and inability to stay still. It affects less than 0.1{\%} of the population and is slightly more prevalent in men than women. Although we have some acute care and preventive medications for both types of headache, no treatment is optimal for each patient and some will not respond well or have significant adverse events to existing therapies.",
keywords = "CGRP, Cluster headache therapy, Headache devices, Migraine therapy, Monoclonal antibodies to calcitonin gene–related peptide or its receptor, Pathophysiology of migraine",
author = "Rapoport, {Alan M} and Lars Edvinsson",
year = "2019",
month = "5",
doi = "10.1007/s10072-019-03828-0",
language = "English",
volume = "40",
pages = "75--80",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer Italia Srl",
number = "Suppl 1",

}

RIS

TY - JOUR

T1 - Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache

AU - Rapoport, Alan M

AU - Edvinsson, Lars

PY - 2019/5

Y1 - 2019/5

N2 - Migraine is a common, severe disease, affecting the brain and blood vessels, causing much pain, time missed from work and family, and severe disability. It affects approximately 12% of most Western populations studied and affects women three times more than men. Cluster headache is a much less common dysfunction of the hypothalamus, involving the sphenopalatine ganglion and other areas; it causes more frequent, shorter, and even more intense pain than migraine. The pain usually comes in cycles and is associated with ipsilateral autonomic features and associated with irritability and inability to stay still. It affects less than 0.1% of the population and is slightly more prevalent in men than women. Although we have some acute care and preventive medications for both types of headache, no treatment is optimal for each patient and some will not respond well or have significant adverse events to existing therapies.

AB - Migraine is a common, severe disease, affecting the brain and blood vessels, causing much pain, time missed from work and family, and severe disability. It affects approximately 12% of most Western populations studied and affects women three times more than men. Cluster headache is a much less common dysfunction of the hypothalamus, involving the sphenopalatine ganglion and other areas; it causes more frequent, shorter, and even more intense pain than migraine. The pain usually comes in cycles and is associated with ipsilateral autonomic features and associated with irritability and inability to stay still. It affects less than 0.1% of the population and is slightly more prevalent in men than women. Although we have some acute care and preventive medications for both types of headache, no treatment is optimal for each patient and some will not respond well or have significant adverse events to existing therapies.

KW - CGRP

KW - Cluster headache therapy

KW - Headache devices

KW - Migraine therapy

KW - Monoclonal antibodies to calcitonin gene–related peptide or its receptor

KW - Pathophysiology of migraine

UR - http://www.scopus.com/inward/record.url?scp=85064158041&partnerID=8YFLogxK

U2 - 10.1007/s10072-019-03828-0

DO - 10.1007/s10072-019-03828-0

M3 - Review

VL - 40

SP - 75

EP - 80

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - Suppl 1

ER -

ID: 57158493